Market Overview

Citron's Andrew Left Thinks Netflix Got 'Ahead Of Itself,' Sees Stock Falling Below $300

Share:
Citron's Andrew Left Thinks Netflix Got 'Ahead Of Itself,' Sees Stock Falling Below $300
Related NFLX
The Oprah Effect: Apple, Winfrey Sign Multiyear Programming Deal
Citron Says Netflix Bulls Need A 'Reality Check'
Will AT&T/Time Warner Ruling Accelerate M&A? (Seeking Alpha)

Notable short seller Andrew Left of Citron Research isn't a fan of Netflix, Inc. (NASDAQ: NFLX) at the stock's current levels.

What Happened

Netflix's stock has seen a "historic run" but multiple factors don't support its valuation north of $300 per share, Left told CNBC's Scott Wapner. The stock "did get ahead of itself" and should see a "quick pass down" from Monday's price of around $330 after adding $17 billion in value within the last week.

Meanwhile, Netflix investors need to ask themselves a serious question that calls into question the stock's massive run, Left said. Specifically, Apple Inc. (NASDAQ: AAPL) can "do what Netflix does, but can Netflix do what Apple does?"

Why It's Important

"The moat is just not there to justify the huge price increases we have seen in the past few weeks," Left said. "[That] doesn't mean it isn't a great company, doesn't mean [Netflix CEO} Reed Hastings hasn't done one of the greatest jobs in all of tech."

Left likes the fact that short interest is at a 10-year low.

"When all the shorts throw the towel in...and the stock's peaking and you see the chart on the stock from the past week, that tells me okay, I like this as an entry point."

Even if Left's short call is correct and the stock dips all the way to $270 per share, long-term investors would still be sitting on a hefty profit.

What's Next

At the end of the day, Left doesn't think Netflix is a bad company, but investors should take their profit. The stock fell about 3.4 percent following Citron's initial tweet and was trading around $320.17 at time of publication.

Related Links:

Citron's Andrew Left Sells Twitter Stake: 'Congrats To Them'

Were The Short Sellers Right? MiMedx Postpones Q4 Report Pending Internal Investigation

Image credit: Matthew Keys, Flickr

Posted-In: Andrew LeftShort Sellers Short Ideas Top Stories Movers Tech Media Trading Ideas Best of Benzinga

 

Related Articles (AAPL + NFLX)

View Comments and Join the Discussion!